Europska Unija - hrvatski - EMA (European Medicines Agency)

pfizer europe ma eeig  - rimegepant - migrena poremećaja - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as kalceks, krustpils iela 53, riga, latvija - pantoprazolnatrij seskvihidrat - prašak za otopinu za injekciju - urbroj: jedna bočica sadrži 40 mg pantoprazola (u obliku natrij seskvihidrata)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - azitromicin dihidrat - filmom obložena tableta - 500 mg - urbroj: jedna filmom obložena tableta sadrži 500 mg azitromicina u obliku azitromicin dihidrata

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as kalceks, krustpils iela 71e, riga, latvija - midazolamklorid - otopina za injekciju/infuziju - 5 mg/ml - urbroj: 1 ml otopine sadrži 5 mg midazolama (u obliku midazolamklorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - azitromicin dihidrat - filmom obložena tableta - 500 mg - urbroj: jedna filmom obložena tableta sadrži 500 mg azitromicina u obliku azitromicindihidrata

Europska Unija - hrvatski - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as kalceks, krustpils iela 71e, riga, latvija - midazolamklorid - otopina za injekciju / infuziju - urbroj: 1 ml otopine sadrži 1 mg midazolama (u obliku midazolamklorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

as kalceks, krustpils iela 71e, riga, latvija - palonozetronklorid - otopina za injekciju - urbroj: jedan ml otopine sadrži 50 mikrograma palonozetrona (u obliku palonozetronklorida) jedna bočica otopine od 5 ml sadrži 250 mikrograma palonozetrona (u obliku palonozetronklorida)

Europska Unija - hrvatski - EMA (European Medicines Agency)

biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Europska Unija - hrvatski - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.